Metabolic-inflammatory index CTI identifies high-risk early-stage natural killer/T-cell lymphoma and informs a novel prognostic model
Qiuhui Jiang, Peng Xu, Huijuan Zhong, Shuhui Fu, Liangjie Wang, Weili Zhao, Shu Cheng, Jie Zha, Bing Xu · 2026
Read Metabolic-inflammatory index CTI identifies high-risk early-stage natural killer/T-cell lymphoma and informs a novel prognostic model by Qiuhui Jiang, Peng Xu, Huijuan Zhong, Shuhui Fu, Liangjie Wang, Weili Zhao, Shu Cheng, Jie Zha, Bing Xu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13579890.txt.
Description
Qiuhui Jiang and co-authors present a study dated 2026 on a blood index that flags high-risk early-stage lymphoma of natural killer and T cells. This cancer behaves very differently between patients, and early-stage cases lack sharp prognostic tools. The team built an index, CTI, from three routine labs: an inflammation marker, blood fat, and blood sugar.
They reanalyzed 166 early-stage patients from a multicenter trial. High CTI values meant clearly worse survival, rising in a straight dose pattern. High-CTI patients also showed more fever-type symptoms and higher stress markers. Animal work and lymphocyte checks probed the biology. A final model combined the index with body mass and a blood protein, and sorted risk well in internal tests.
Catalog record
| CREATOR | Qiuhui Jiang, Peng Xu, Huijuan Zhong, Shuhui Fu, Liangjie Wang, Weili Zhao, Shu Cheng, Jie Zha, Bing Xu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |